Antihypertensive Treatment With ACE Inhibitors or -Blockers and Risk of Incident Atrial Fibrillation in a General Hypertensive Population
Open Access
- 1 May 2009
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 22 (5), 538-544
- https://doi.org/10.1038/ajh.2009.33
Abstract
Background. Secondary analyses of clinical trial data suggest that, compared with other agents, angiotensin-converting enzyme (ACE) inhibitors and angiKeywords
This publication has 28 references indexed in Scilit:
- Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trialJournal Of Hypertension, 2008
- Structural and Functional Remodeling of the Left AtriumJournal of the American College of Cardiology, 2008
- Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation?American Heart Journal, 2007
- Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysisEuropean Heart Journal, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillationAmerican Heart Journal, 2006
- Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future PrevalenceCirculation, 2006
- Effects of Quinapril on Left Atrial Structural Remodeling and Arterial StiffnessThe American Journal of Cardiology, 2006
- Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenololJournal of the American College of Cardiology, 2005
- Atrial Fibrillation in HypertensionHypertension, 2003